Amarin spent years, millions of dollars and a lot of willpower proving its fish oil-based drug Vascepa really could cut the risk of heart attacks, strokes and other cardiovascular problems. To make that effort pay off, it needs to keep that proof to itself. That's just what the drugmaker did in settling two lawsuits with fish oil supplement manufacturers who'd allegedly co-opted the results of Amarin's landmark Reduce-It trial. And in touting its double win, Amarin said it has lawyer...
READ MORE
|
Lawmakers are raising concerns anew about the U.S. reliance on foreign drug manufacturing amid the Wuhan coronavirus outbreak that has pushed FDA inspectors out of China. The novel disease outbreak could spark medical product shortages if the epidemic is not resolved swiftly, experts say. The challenges come as Chinese drug manufacturing has been in Congress's spotlight following a series of warnings last year about contaminated batches of foreign-made drugs. “There is emerging and I t...
READ MORE
|
Could a drug's price ever be too low? That’s what some market-watchers are asking in the Netherlands, where AbbVie is discounting Humira as much as 89%. The De Groene Amsterdammer dug into the procurement process for Humira biosimilars after they launched in Europe last year and turned up aggressive discounts that have effectively held off biosimilar rivals. And some of those would-be competitors have pulled back from the market because of those discounts, the newspaper reports. At lea...
FIERCEPHARMA
READ MORE
|
New county rules will require alcohol sellers to card all purchasers, no matter their age. The policy will go into effect July 1 for all 27 liquor stores run by the county....
READ MORE
|
Australian biotech Immutep has begun a clinical trial partnership with Germany’s Merck KGaA and Pfizer to develop a new cancer immunotherapy combination therapy. Sydney-based Immutep will develop its immunotherapy eftilagimod alpha (left) in combination with Merck and Pfizer’s anti PD-L1 antibody avelumab in patients with advanced solid tumors.
A planned clinical evaluation will be an amendment to the existing INSIGHT phase I clinical trial and will evaluate the safety, tolera...
READ MORE
|
DECK 7 Inc., a top lead generation company based in San Diego, California, has gone beyond its peers and competitors in their digital marketing efforts for 2020. An esteemed digital marketing and media company, known for executing campaign management and content services to its clients and partners worldwide, DECK 7 has built a comprehensive system to track buyers and influencers, build behavioral models, and putting all the vast intelligence it generates into the hands of its marketing partners...
DECK 7
READ MORE
|